Neil Dhopeshwarkar

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Venous Thromboembolism

Atrial Fibrillation

Health Insurance

Top Venues

American journal of hematology

Clinical pharmacology and therapeutics

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Neil Dhopeshwarkar, Wei Yang, Sean Hennessy, Joanna M Rhodes, Adam Cuker, Charles E Leonard
Combining Super Learner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemia. Pharmacoepidemiology and drug safety (2023)
Neil Dhopeshwarkar, Wei Yang, Sean Hennessy, Joanna M Rhodes, Adam Cuker, Charles E Leonard
Rate of major bleeding with ibrutinib versus bendamustine-rituximab in chronic lymphocytic leukemia: A population-based cohort study. American journal of hematology 97 (9) (2022)
Neil Dhopeshwarkar, Wei Yang, Sean Hennessy, Joanna M Rhodes, Adam Cuker, Charles E Leonard
Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study. American journal of hematology (2022)
Ghadeer K Dawwas, Sean Hennessy, Colleen M Brensinger, Rajat Deo, Warren B Bilker, Samantha E Soprano, Neil Dhopeshwarkar, James H Flory, Zachary T Bloomgarden, Christina L Aquilante, Stephen E Kimmel, Charles E Leonard
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies. Clinical pharmacology and therapeutics (2021)